Related Experiment Videos

Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages

Erwei Song1, Sang-Kyung Lee, Derek M Dykxhoorn

  • 1Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA.

Journal of Virology
|June 14, 2003
PubMed

Insights

Small interfering RNAs (siRNAs) offer sustained human immunodeficiency virus type 1 (HIV-1) inhibition in macrophages. Targeting CCR5 provides long-lasting gene silencing, crucial for controlling HIV-1 reservoirs.

Area of Science:

  • Molecular Biology
  • Virology
  • Immunology

Background:

  • Small interfering RNAs (siRNAs) induce gene silencing by degrading mRNA.
  • In dividing cells, siRNA silencing is transient (3-7 days) due to dilution.
  • Macrophages are a key in vivo reservoir for HIV-1.

Purpose of the Study:

  • To investigate sustained siRNA-mediated silencing of HIV-1 in macrophages.
  • To assess the potential of targeting CCR5 and p24 for long-term HIV-1 inhibition.

Main Methods:

  • Macrophages were transfected with siRNAs targeting CCR5 and/or p24.
  • Cells were infected with HIV-1 at various time points post-transfection.
  • HIV-1 infection levels and siRNA persistence were analyzed.

Main Results:

  • CCR5 and p24 siRNAs reduced HIV-1 infection for 15 days when transfected before infection.
  • p24 siRNA efficacy decreased by day 7, while CCR5 siRNA provided sustained inhibition.
  • Long-term HIV-1 suppression was achieved with p24 siRNA in established infections.

Conclusions:

  • Sustained siRNA-mediated HIV-1 inhibition is possible in terminally differentiated macrophages.
  • Targeting cellular CCR5 offers longer-lasting silencing than targeting viral p24 in uninfected cells.
  • siRNAs represent a potent strategy for long-term HIV-1 control in non-dividing cells.

Related Concept Videos